The global Amyotrophic Lateral Sclerosis Therapeutics market was valued at US$ 300 million in 2023 and is anticipated to reach US$ 396.8 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.

Amyotrophic Lateral Sclerosis Therapeutics Market

Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig’s disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die.

The cause is not known in 90% to 95% of cases. The remaining 5–10% of cases are inherited from a person's parents. About half of these genetic cases are due to one of two specific genes. The underlying mechanism involves damage to both upper and lower motor neurons. The diagnosis is based on a person's signs and symptoms, with testing done to rule out other potential causes.

The amyotrophic lateral sclerosis (ALS) therapeutics market is driven by the increasing prevalence of ALS and the growing demand for effective treatments to slow disease progression and improve patient outcomes. As the understanding of ALS pathophysiology improves, researchers and pharmaceutical companies are actively exploring novel therapeutic approaches, including gene therapies and immune-modulating agents. The approval of new ALS drugs and the development of combination therapies further propel market growth. However, challenges include the complexity of ALS as a multi-factorial disease, the difficulty in diagnosing ALS at an early stage, and the high cost of drug development and clinical trials. Addressing these challenges through collaborative research, improved diagnostic tools, and accessible treatment options will be crucial for the sustained growth of the ALS therapeutics market.

This report aims to provide a comprehensive presentation of the global market for Amyotrophic Lateral Sclerosis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amyotrophic Lateral Sclerosis Therapeutics.

Report Scope

The Amyotrophic Lateral Sclerosis Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amyotrophic Lateral Sclerosis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Amyotrophic Lateral Sclerosis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Amyotrophic Lateral Sclerosis Therapeutics Market Report

Report Metric	Details
Report Name	Amyotrophic Lateral Sclerosis Therapeutics Market
Accounted market size in 2023	US$ 300 million
Forecasted market size in 2030	US$ 396.8 million
CAGR	3.4%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Riluzole Edaravone (Radicava) Other
Segment by Application	Hospital Drugs Store Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Mitsubishi Tanabe Pharma, Sanofi, Mylan Pharma, Apotex, Glemark Generics, Covis Pharma, Sun Pharma, Lunan Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Amyotrophic Lateral Sclerosis Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Amyotrophic Lateral Sclerosis Therapeutics Market growing?

Ans: The Amyotrophic Lateral Sclerosis Therapeutics Market witnessing a CAGR of 3.4% during the forecast period 2024-2030.

What is the Amyotrophic Lateral Sclerosis Therapeutics Market size in 2030?

Ans: The Amyotrophic Lateral Sclerosis Therapeutics Market size in 2030 will be US$ 396.8 million.

Who are the main players in the Amyotrophic Lateral Sclerosis Therapeutics Market report?

Ans: The main players in the Amyotrophic Lateral Sclerosis Therapeutics Market are Mitsubishi Tanabe Pharma, Sanofi, Mylan Pharma, Apotex, Glemark Generics, Covis Pharma, Sun Pharma, Lunan Pharma

What are the Application segmentation covered in the Amyotrophic Lateral Sclerosis Therapeutics Market report?

Ans: The Applications covered in the Amyotrophic Lateral Sclerosis Therapeutics Market report are Hospital, Drugs Store, Other

What are the Type segmentation covered in the Amyotrophic Lateral Sclerosis Therapeutics Market report?

Ans: The Types covered in the Amyotrophic Lateral Sclerosis Therapeutics Market report are Riluzole, Edaravone (Radicava), Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Riluzole

1.2.3 Edaravone (Radicava)

1.2.4 Other

1.3 Market by Application

1.3.1 Global Amyotrophic Lateral Sclerosis Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Drugs Store

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Amyotrophic Lateral Sclerosis Therapeutics Market Perspective (2019-2030)

2.2 Amyotrophic Lateral Sclerosis Therapeutics Growth Trends by Region

2.2.1 Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Amyotrophic Lateral Sclerosis Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Amyotrophic Lateral Sclerosis Therapeutics Market Dynamics

2.3.1 Amyotrophic Lateral Sclerosis Therapeutics Industry Trends

2.3.2 Amyotrophic Lateral Sclerosis Therapeutics Market Drivers

2.3.3 Amyotrophic Lateral Sclerosis Therapeutics Market Challenges

2.3.4 Amyotrophic Lateral Sclerosis Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Amyotrophic Lateral Sclerosis Therapeutics Players by Revenue

3.1.1 Global Top Amyotrophic Lateral Sclerosis Therapeutics Players by Revenue (2019-2024)

3.1.2 Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Amyotrophic Lateral Sclerosis Therapeutics Revenue

3.4 Global Amyotrophic Lateral Sclerosis Therapeutics Market Concentration Ratio

3.4.1 Global Amyotrophic Lateral Sclerosis Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis Therapeutics Revenue in 2023

3.5 Amyotrophic Lateral Sclerosis Therapeutics Key Players Head office and Area Served

3.6 Key Players Amyotrophic Lateral Sclerosis Therapeutics Product Solution and Service

3.7 Date of Enter into Amyotrophic Lateral Sclerosis Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Amyotrophic Lateral Sclerosis Therapeutics Breakdown Data by Type

4.1 Global Amyotrophic Lateral Sclerosis Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Type (2025-2030)

5 Amyotrophic Lateral Sclerosis Therapeutics Breakdown Data by Application

5.1 Global Amyotrophic Lateral Sclerosis Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size (2019-2030)

6.2 North America Amyotrophic Lateral Sclerosis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2019-2024)

6.4 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size (2019-2030)

7.2 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2019-2024)

7.4 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size (2019-2030)

9.2 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2019-2024)

9.4 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Mitsubishi Tanabe Pharma

11.1.1 Mitsubishi Tanabe Pharma Company Detail

11.1.2 Mitsubishi Tanabe Pharma Business Overview

11.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Introduction

11.1.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

11.1.5 Mitsubishi Tanabe Pharma Recent Development

11.2 Sanofi

11.2.1 Sanofi Company Detail

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Amyotrophic Lateral Sclerosis Therapeutics Introduction

11.2.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

11.2.5 Sanofi Recent Development

11.3 Mylan Pharma

11.3.1 Mylan Pharma Company Detail

11.3.2 Mylan Pharma Business Overview

11.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Introduction

11.3.4 Mylan Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

11.3.5 Mylan Pharma Recent Development

11.4 Apotex

11.4.1 Apotex Company Detail

11.4.2 Apotex Business Overview

11.4.3 Apotex Amyotrophic Lateral Sclerosis Therapeutics Introduction

11.4.4 Apotex Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

11.4.5 Apotex Recent Development

11.5 Glemark Generics

11.5.1 Glemark Generics Company Detail

11.5.2 Glemark Generics Business Overview

11.5.3 Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Introduction

11.5.4 Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

11.5.5 Glemark Generics Recent Development

11.6 Covis Pharma

11.6.1 Covis Pharma Company Detail

11.6.2 Covis Pharma Business Overview

11.6.3 Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Introduction

11.6.4 Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

11.6.5 Covis Pharma Recent Development

11.7 Sun Pharma

11.7.1 Sun Pharma Company Detail

11.7.2 Sun Pharma Business Overview

11.7.3 Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Introduction

11.7.4 Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

11.7.5 Sun Pharma Recent Development

11.8 Lunan Pharma

11.8.1 Lunan Pharma Company Detail

11.8.2 Lunan Pharma Business Overview

11.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Introduction

11.8.4 Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

11.8.5 Lunan Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Mitsubishi Tanabe Pharma

List of Tables

Table 1. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Riluzole

Table 3. Key Players of Edaravone (Radicava)

Table 4. Key Players of Other

Table 5. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Region (2019-2024)

Table 9. Global Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Region (2025-2030)

Table 11. Amyotrophic Lateral Sclerosis Therapeutics Market Trends

Table 12. Amyotrophic Lateral Sclerosis Therapeutics Market Drivers

Table 13. Amyotrophic Lateral Sclerosis Therapeutics Market Challenges

Table 14. Amyotrophic Lateral Sclerosis Therapeutics Market Restraints

Table 15. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Players (2019-2024)

Table 17. Global Top Amyotrophic Lateral Sclerosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyotrophic Lateral Sclerosis Therapeutics as of 2023)

Table 18. Ranking of Global Top Amyotrophic Lateral Sclerosis Therapeutics Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Amyotrophic Lateral Sclerosis Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Amyotrophic Lateral Sclerosis Therapeutics Product Solution and Service

Table 22. Date of Enter into Amyotrophic Lateral Sclerosis Therapeutics Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Type (2019-2024)

Table 26. Global Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Type (2025-2030)

Table 28. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Application (2019-2024)

Table 30. Global Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Application (2025-2030)

Table 32. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 47. Mitsubishi Tanabe Pharma Company Detail

Table 48. Mitsubishi Tanabe Pharma Business Overview

Table 49. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Product

Table 50. Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024) & (US$ Million)

Table 51. Mitsubishi Tanabe Pharma Recent Development

Table 52. Sanofi Company Detail

Table 53. Sanofi Business Overview

Table 54. Sanofi Amyotrophic Lateral Sclerosis Therapeutics Product

Table 55. Sanofi Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024) & (US$ Million)

Table 56. Sanofi Recent Development

Table 57. Mylan Pharma Company Detail

Table 58. Mylan Pharma Business Overview

Table 59. Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Product

Table 60. Mylan Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024) & (US$ Million)

Table 61. Mylan Pharma Recent Development

Table 62. Apotex Company Detail

Table 63. Apotex Business Overview

Table 64. Apotex Amyotrophic Lateral Sclerosis Therapeutics Product

Table 65. Apotex Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024) & (US$ Million)

Table 66. Apotex Recent Development

Table 67. Glemark Generics Company Detail

Table 68. Glemark Generics Business Overview

Table 69. Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Product

Table 70. Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024) & (US$ Million)

Table 71. Glemark Generics Recent Development

Table 72. Covis Pharma Company Detail

Table 73. Covis Pharma Business Overview

Table 74. Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Product

Table 75. Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024) & (US$ Million)

Table 76. Covis Pharma Recent Development

Table 77. Sun Pharma Company Detail

Table 78. Sun Pharma Business Overview

Table 79. Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Product

Table 80. Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024) & (US$ Million)

Table 81. Sun Pharma Recent Development

Table 82. Lunan Pharma Company Detail

Table 83. Lunan Pharma Business Overview

Table 84. Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Product

Table 85. Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024) & (US$ Million)

Table 86. Lunan Pharma Recent Development

Table 87. Research Programs/Design for This Report

Table 88. Key Data Information from Secondary Sources

Table 89. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Riluzole Features

Figure 4. Edaravone (Radicava) Features

Figure 5. Other Features

Figure 6. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application: 2023 VS 2030

Figure 8. Hospital Case Studies

Figure 9. Drugs Store Case Studies

Figure 10. Other Case Studies

Figure 11. Amyotrophic Lateral Sclerosis Therapeutics Report Years Considered

Figure 12. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Region: 2023 VS 2030

Figure 15. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Players in 2023

Figure 16. Global Top Amyotrophic Lateral Sclerosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyotrophic Lateral Sclerosis Therapeutics as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Amyotrophic Lateral Sclerosis Therapeutics Revenue in 2023

Figure 18. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Country (2019-2030)

Figure 20. United States Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Share by Country (2019-2030)

Figure 24. Germany Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Share by Region (2019-2030)

Figure 32. China Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Country (2019-2030)

Figure 40. Mexico Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Share by Country (2019-2030)

Figure 44. Turkey Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Mitsubishi Tanabe Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

Figure 47. Sanofi Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

Figure 48. Mylan Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

Figure 49. Apotex Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

Figure 50. Glemark Generics Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

Figure 51. Covis Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

Figure 52. Sun Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

Figure 53. Lunan Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions